Relation between hemoglobin A 1c and outcomes in heart failure patients with and without diabetes mellitus

American Journal of Cardiology

Volumn 109, Issue 12, 2012, Pages 1767-1773

  Tomova, G Sofia ^b   Nimbal, Vani ^c   Horwich, Tamara B ^a  

^a Department of Medicine   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALDOSTERONE ANTAGONIST; ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BRAIN NATRIURETIC PEPTIDE; CHOLESTEROL; CREATININE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HEMOGLOBIN; HEMOGLOBIN A1C;

ADULT; ARTICLE; BODY MASS; CARDIAC RESYNCHRONIZATION THERAPY; CARDIOMETABOLIC RISK; CARDIOVASCULAR MORTALITY; CHOLESTEROL BLOOD LEVEL; CREATININE BLOOD LEVEL; DEATH; DEFIBRILLATOR; DIABETES MELLITUS; DISEASE ASSOCIATION; EVENT FREE SURVIVAL; FEMALE; GLYCOSYLATION; HEART DEATH; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE ENDDIASTOLIC VOLUME; HEART MUSCLE OXYGEN CONSUMPTION; HEART RATE; HEART TRANSPLANTATION; HEMOGLOBIN BLOOD LEVEL; HUMAN; LUNG WEDGE PRESSURE; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; SYSTOLIC BLOOD PRESSURE; UREA NITROGEN BLOOD LEVEL;

ADULT; AGED; CASE-CONTROL STUDIES; COHORT STUDIES; DIABETES MELLITUS; FEMALE; FOLLOW-UP STUDIES; HEART FAILURE; HEART TRANSPLANTATION; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; MALE; MIDDLE AGED; PROGNOSIS; RISK FACTORS; SURVIVAL RATE; VENTRICULAR FUNCTION, LEFT;

EID: 84861583828     PISSN: 00029149     EISSN: 18791913     Source Type: Journal    
DOI: 10.1016/j.amjcard.2012.02.022     Document Type: Article

References (21)

1. D. Preiss, S. Zetterstrand, J.J.V. McMurray, J. Östergren, E.L. Michelson, C.B. Granger, S. Yusuf, K. Swedberg, M.A. Pfeffer, H.C. Gerstein, N. Sattar Predictors of development of diabetes in patients with chronic heart failure in the Candesartan in Heart Failure Assessment Of Reduction In Mortality And Morbidity (CHARM) program Diabetes Care 32 2009 915 920
2. G.A. Nichols, C.M. Gullion, C.E. Koro, S.A. Ephross, J.B. Brown The incidence of congestive heart failure in type 2 diabetes Diabetes Care 27 2004 1879 1884
3. J.B. Kostis, M. Sanders The association of heart failure with insulin resistance and the development of type 2 diabetes Am J Hypertens 18 2005 731 737
4. C. Iribarren, A.J. Karter, A.S. Go, A. Ferrara, J.Y. Liu, S. Sidney, J.V. Selby Glycemic control and heart failure among adult patients with diabetes Circulation 103 2001 2668 2673
5. S. Eshaghian, T.B. Horwich, G.C. Fonarow An unexpected inverse relationship between HbA1c levels and mortality in patients with diabetes and advanced systolic heart failure Am Heart J 151 2006 91
6. D. Aguilar, B. Bozkurt, K. Ramasubbu, A. Deswal Relationship of hemoglobin A1C and mortality in heart failure patients with diabetes J Am Coll Cardiol 54 2009 422 428
7. H.C. Gerstein, K. Swedberg, J. Carlsson, J.J.V. McMurray, E.L. Michelson, B. Olofsson, M.A. Pfeffer, S. Yusuf The hemoglobin A1c level as a progressive risk factor for cardiovascular death, hospitalization for heart failure, or death in patients with chronic heart failure: an analysis of the Candesartan in Heart Failure: Assessment of Reduction in Mortality and Morbidity (CHARM) program Arch Intern Med 168 2008 1699 1704
8. M.R. MacDonald, P.S. Jhund, M.C. Petrie, J.D. Lewsey, N.M. Hawkins, S. Bhagra, N. Munoz, F. Varyani, A. Redpath, J. Chalmers, K. MacIntyre, J.J.V. McMurray Discordant short- and long-term outcomes associated with diabetes in patients with heart failure: importance of age and sex Circ Heart Fail 1 2008 234 241
9. I. Gustafsson, B. Brendorp, M. Seibaek, H. Burchardt, P. Hildebrandt, L. Kober, C. Torp-Pedersen DIAMOND Study Group Influence of diabetes and diabetes-gender interaction on the risk of death in patients hospitalized with congestive heart failure J Am Coll Cardiol 43 2004 771 777
10. S. Smooke, T.B. Horwich, G.C. Fonarow Insulin-treated diabetes is associated with a marked increase in mortality in patients with advanced heart failure American Heart Journal 149 2005 168 174
11. Tests of glycemia in diabetes Diabetes Care 26 2003 s106 s108
12. V.M. Montori, M. Fernández-Balsells Glycemic control in type 2 diabetes: time for an evidence-based about-face? Ann Intern Med 150 2009 803 808
13. H.C. Gerstein, M.E. Miller, S. Genuth, F. Ismail-Beigi, J.B. Buse, D.C. Goff Jr, J.L. Probstfield, W.C. Cushman, H.N. Ginsberg, J.T. Bigger, R.H. Grimm Jr, R.P. Byington, Y.D. Rosenberg, W.T. Friedewald ACCORD Study Group Long-term effects of intensive glucose lowering on cardiovascular outcomes N Engl J Med 364 2011 818 828
14. J.S. Skyler, R. Bergenstal, R.O. Bonow, J. Buse, P. Deedwania, E.A.M. Gale, B.V. Howard, M.S. Kirkman, M. Kosiborod, P. Reaven, R.S. Sherwin Intensive glycemic control and the prevention of cardiovascular events: implications of the ACCORD, ADVANCE, and VA diabetes trials: a position statement of the American Diabetes Association and a scientific statement of the American College of Cardiology Foundation and the American Heart Association J Am Coll Cardiol 53 2009 298 304
15. K. Kalantar-Zadeh, G. Block, T. Horwich, G.C. Fonarow Reverse epidemiology of conventional cardiovascular risk factors in patients with chronic heart failure J Am Coll Cardiol 43 2004 1439 1444
16. A.P. Carson, C.S. Fox, D.K. McGuire, E.B. Levitan, M. Laclaustra, D.M. Mann, P. Muntner Low hemoglobin A1c and risk of all-cause mortality among US adults without diabetes Circ Cardiovasc Qual Outcomes 3 2010 661 667
17. H. Ashrafian, M.P. Frenneaux, L.H. Opie Metabolic mechanisms in heart failure Circulation 116 2007 434 448
18. D.D. Shah, G.C. Fonarow, T.B. Horwich Metformin therapy and outcomes in patients with advanced systolic heart failure and diabetes J Card Fail 16 2010 200 206
19. F.A. Masoudi, S.E. Inzucchi, Y. Wang, E.P. Havranek, J.M. Foody, H.M. Krumholz Thiazolidinediones, metformin, and outcomes in older patients with diabetes and heart failure Circulation 111 2005 583 590
20. G. Guder, S. Frantz, J. Bauersachs, B. Allolio, C. Wanner, M.T. Koller, G. Ertl, C.E. Angermann, S. Stork Reverse epidemiology in systolic and nonsystolic heart failure: cumulative prognostic benefit of classical cardiovascular risk factors Circ Heart Fail 2 2009 563 571
21. A.D. Association Diagnosis and classification of diabetes mellitus Diabetes Care 33 2010 S62 S69